U.S. Markets closed

Tandem Diabetes reports 4Q loss

SAN DIEGO (AP) _ Tandem Diabetes Care Inc. (TNDM) on Wednesday reported a loss of $14.8 million in its fourth quarter.

The San Diego-based company said it had a loss of 48 cents per share.

The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 63 cents per share.

The insulin pump maker posted revenue of $28.9 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $23.7 million.

For the year, the company reported that its loss widened to $83.4 million, or $2.73 per share. Revenue was reported as $84.2 million.

In the final minutes of trading on Wednesday, the company's shares hit $2.15. A year ago, they were trading at $9.98.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TNDM at https://www.zacks.com/ap/TNDM


Keywords: Tandem Diabetes, Earnings Report